XML 43 R31.htm IDEA: XBRL DOCUMENT
v3.25.2

Financial Instruments (Tables) | 8 Months Ended
--- | ---
Sep. 06, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Schedule of Notional Amounts of Financial Instruments | The notional amounts of our financial instruments used to hedge the above risks are as follows:
| Notional Amounts(a)
| 9/6/2025 |  | 12/28/2024
Commodity contracts | $ | 1.3 |  |  | $ | 1.4 |
Interest rate swap contracts | $ | 2.0 |  |  | $ | 2.0 |
Foreign exchange contracts | $ | 3.2 |  |  | $ | 3.1 |
Cross-currency contracts | $ | 1.7 |  |  | $ | 1.2 |
Non-derivative debt instruments | $ | 4.3 |  |  | $ | 2.9 |
(a)In billions.
Debt Securities, Available-for-Sale | The activity related to our Level 3 investments in certain available-for-sale debt securities is as follows:
|  |  |  |  | 12 Weeks Ended |  | 36 Weeks Ended
|  |  |  |  | 9/6/2025 |  | 9/7/2024 |  | 9/6/2025 |  | 9/7/2024
Celsius: |  |  |  |  |  |  |  |  |  |  |
Balance, beginning of period |  |  |  |  | $ | 958 |  |  | $ | 1,337 |  |  | $ | 785 |  |  | $ | 1,156 |
Acquired |  |  |  |  | 590 |  |  | — |  |  | 590 |  |  | — |
Net unrealized gain/(loss) |  |  |  |  | 535 |  |  | (453) |  |  | 722 |  |  | (265) |
Cash dividends received |  |  |  |  | (6) |  |  | (7) |  |  | (20) |  |  | (14) |
Balance, end of period |  |  |  |  | $ | 2,077 |  |  | $ | 877 |  |  | $ | 2,077 |  |  | $ | 877 |
Other: |  |  |  |  |  |  |  |  |  |  |
Balance, beginning of period |  |  |  |  | $ | 261 |  |  | $ | — |  |  | $ | 256 |  |  | $ | — |
Net unrealized gain/(loss) |  |  |  |  | 6 |  |  | — |  |  | 11 |  |  | — |
Balance, end of period |  |  |  |  | $ | 267 |  |  | $ | — |  |  | $ | 267 |  |  | $ | — |
Total Level 3 available-for-sale balance, end of period |  |  |  |  | $ | 2,344 |  |  | $ | 877 |  |  | $ | 2,344 |  |  | $ | 877 |
Summary of Fair Values of Financial Assets and Liabilities | The fair values of our financial assets and liabilities are categorized as follows:
|  |  | 9/6/2025 |  | 12/28/2024
| Fair Value Hierarchy Levels(a) |  | Assets(a) |  | Liabilities(a) |  | Assets(a) |  | Liabilities(a)
Available-for-sale debt securities (b) | 3 |  | $ | 2,344 |  |  | $ | — |  |  | $ | 1,041 |  |  | $ | — |
Index funds (c) | 1 |  | $ | 325 |  |  | $ | — |  |  | $ | 336 |  |  | $ | — |
Prepaid forward contracts (d) | 2 |  | $ | 9 |  |  | $ | — |  |  | $ | 15 |  |  | $ | — |
Deferred compensation (e) | 2 |  | $ | — |  |  | $ | 485 |  |  | $ | — |  |  | $ | 503 |
Contingent consideration (f) | 3 |  | $ | — |  |  | $ | 180 |  |  | $ | — |  |  | $ | — |
Derivatives designated as fair value hedging instruments: |  |  |  |
Interest rate swap contracts (g) | 2 |  | $ | 31 |  |  | $ | 1 |  |  | $ | — |  |  | $ | 46 |
Derivatives designated as cash flow hedging instruments: |  |  |  |
Foreign exchange contracts (h) | 2 |  | $ | 8 |  |  | $ | 32 |  |  | $ | 55 |  |  | $ | 3 |
Cross-currency contracts (h) | 2 |  | — |  |  | 105 |  |  | — |  |  | 165 |
Commodity contracts (i) | 2 |  | 86 |  |  | 8 |  |  | 27 |  |  | 6 |
|  |  | $ | 94 |  |  | $ | 145 |  |  | $ | 82 |  |  | $ | 174 |
Derivatives designated as net investment hedging instruments: |  |  |  |
Cross-currency contracts (h) | 2 |  | $ | — |  |  | $ | 16 |  |  | $ | 1 |  |  | $ | 4 |
Derivatives not designated as hedging instruments: |  |  |  |
Foreign exchange contracts (h) | 2 |  | $ | 6 |  |  | $ | 12 |  |  | $ | 28 |  |  | $ | 12 |
Commodity contracts (i) | 2 |  | 1 |  |  | 11 |  |  | 3 |  |  | 10 |
|  |  | $ | 7 |  |  | $ | 23 |  |  | $ | 31 |  |  | $ | 22 |
Total derivatives at fair value (j) |  |  | $ | 132 |  |  | $ | 185 |  |  | $ | 114 |  |  | $ | 246 |
Total |  |  | $ | 2,810 |  |  | $ | 850 |  |  | $ | 1,506 |  |  | $ | 749 |
(a)Fair value hierarchy levels are categorized consistently by Level 1 (quoted prices in active markets for identical assets), Level 2 (significant other observable inputs) and Level 3 in both years. Unless otherwise noted, financial assets are classified on our balance sheet within prepaid expenses and other current assets and other assets. Financial liabilities are classified on our balance sheet within accounts payable and other current liabilities and other liabilities. (b)Classified as other assets. Includes $2,077 million and $785 million related to our investment in Celsius as of September 6, 2025 and December 28, 2024, respectively; also, includes $267 million and $256 million related to our other investment in available-for-sale debt securities as of September 6, 2025 and December 28, 2024, respectively. The fair value of our Level 3 investment in Celsius is estimated using probability-weighted discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as an 80% probability that a certain market-based condition will be met and an average estimated discount rate of 10.1% and 7.3% as of September 6, 2025 and December 28, 2024, respectively. The fair value of the other Level 3 investment is estimated using a lattice model primarily based on the underlying stock price, volatility and certain significant unobservable inputs, such as a discount rate of 8.3% based on an estimated synthetic credit rating. An increase in the probability that certain market-based conditions will be met or a decrease in the discount rate would result in a higher fair value measurement, while a decrease in the probability that certain market-based conditions will be met or an increase in the discount rate would result in a lower fair value measurement. (c)Based on the price of index funds. These investments are classified as short-term investments and are used to manage a portion of market risk arising from our deferred compensation liability. (d)Based primarily on the price of our common stock. (e)Based on the fair value of investments corresponding to employees’ investment elections. (f)In connection with our acquisition of poppi, we recorded a liability at fair value for the contingent consideration payable upon achievement of certain performance milestones by the third quarter of 2027, with a maximum payment of $300 million. If these performance milestones are not met, no payment will be made. The fair value of the liability is estimated using discounted future cash flows based on a Monte Carlo simulation using significant unobservable inputs such as forecasts of net revenue and margin. An increase in the net revenue and margin forecasts would result in a higher fair value measurement, while a decrease in the net revenue and margin forecasts would result in a lower fair value measurement. (g)Based on Secured Overnight Financing Rate forward rates. As of September 6, 2025, the carrying amount of hedged fixed-rate debt was $2.0 billion, which was classified on the balance sheet within long-term debt obligations. (h)Based on recently reported market transactions of spot and forward rates. (i)Primarily based on recently reported market transactions of swap arrangements. (j)Derivative assets and liabilities are presented on a gross basis on our balance sheet. Amounts subject to enforceable master netting arrangements or similar agreements which are not offset on our balance sheet as of September 6, 2025 and December 28, 2024 were not material. Collateral received or posted against our asset or liability positions was not material. Exchange-traded commodity futures are cash-settled on a daily basis and, therefore, not included in the table.
Summary of Losses (Gains) On Derivative Instruments | Losses/(gains) on our fair value hedges recognized in the income statement are as follows:
|  |  |  |  | 12 Weeks Ended |  | 36 Weeks Ended
|  |  |  |  | 9/6/2025 |  | 9/7/2024 |  | 9/6/2025 |  | 9/7/2024
Interest rate swap contracts (a) |  |  |  |  | $ | (33) |  |  | $ | — |  |  | $ | (76) |  |  | $ | — |
(a)Interest rate derivative losses/(gains) are included in net interest expense and other. These losses/(gains) are substantially offset by decreases/increases in the value of the underlying debt, which are also included in net interest expense and other. Losses/(gains) on our cash flow hedges are categorized as follows:
| 12 Weeks Ended
| Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss |  | Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(a)
| 9/6/2025 |  | 9/7/2024 |  | 9/6/2025 |  | 9/7/2024
Foreign exchange contracts | $ | 8 |  |  | $ | (33) |  |  | $ | 13 |  |  | $ | (3) |
Cross-currency contracts | (5) |  |  | (15) |  |  | (8) |  |  | (21) |
Commodity contracts | (38) |  |  | 75 |  |  | (10) |  |  | 34 |
Total | $ | (35) |  |  | $ | 27 |  |  | $ | (5) |  |  | $ | 10 |
|  |  |  |  | 36 Weeks Ended
|  |  | Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss |  | Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(a)
|  |  |  |  | 9/6/2025 |  | 9/7/2024 |  | 9/6/2025 |  | 9/7/2024
Foreign exchange contracts |  |  |  |  | $ | 78 |  |  | $ | (48) |  |  | $ | (11) |  |  | $ | 15 |
Cross-currency contracts |  |  |  |  | (60) |  |  | 19 |  |  | (63) |  |  | 14 |
Commodity contracts |  |  |  |  | (138) |  |  | 103 |  |  | (15) |  |  | 85 |
Total |  |  |  |  | $ | (120) |  |  | $ | 74 |  |  | $ | (89) |  |  | $ | 114 |
(a)Foreign exchange derivative losses/(gains) are included in net revenue and cost of sales. Cross-currency interest rate swap derivative losses/(gains) are included in selling, general and administrative expenses. Commodity derivative losses/(gains) are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. See Note 11 for further information. Losses/(gains) on our net investment hedges are categorized as follows:
|  |  |  |  | 12 Weeks Ended
|  |  | Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss |  | Losses/(Gains) Recognized in Income Statement(a)
|  |  |  |  | 9/6/2025 |  | 9/7/2024 |  | 9/6/2025 |  | 9/7/2024
Non-derivative debt instruments |  |  |  |  | $ | 27 |  |  | $ | 114 |  |  | $ | — |  |  | $ | — |
Cross-currency contracts |  |  |  |  | 4 |  |  | 13 |  |  | (3) |  |  | (2) |
Foreign exchange contracts |  |  |  |  | (13) |  |  | — |  |  | — |  |  | — |
Total |  |  |  |  | $ | 18 |  |  | $ | 127 |  |  | $ | (3) |  |  | $ | (2) |
|  |  |  |  | 36 Weeks Ended
|  |  | Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss |  | Losses/(Gains) Recognized in Income Statement(a)
|  |  |  |  | 9/6/2025 |  | 9/7/2024 |  | 9/6/2025 |  | 9/7/2024
Non-derivative debt instruments |  |  |  |  | $ | 311 |  |  | $ | 45 |  |  | $ | — |  |  | $ | — |
Cross-currency contracts |  |  |  |  | 13 |  |  | 13 |  |  | (7) |  |  | (2) |
Foreign exchange contracts |  |  |  |  | (13) |  |  | — |  |  | — |  |  | — |
Total |  |  |  |  | $ | 311 |  |  | $ | 58 |  |  | $ | (7) |  |  | $ | (2) |
(a)Amount excluded from the assessment of effectiveness recognized in earnings associated with cross-currency interest rate swaps.
Derivatives Not Designated as Hedging Instruments | Losses/(gains) recognized in the income statement related to our non-designated hedges are categorized as follows:
| 12 Weeks Ended
| 9/6/2025 |  | 9/7/2024
| Cost of sales |  | Selling, general and administrative expenses |  | Total |  | Cost of sales |  | Selling, general and administrative expenses |  | Total
Foreign exchange contracts | $ | — |  |  | $ | (3) |  |  | $ | (3) |  |  | $ | 1 |  |  | $ | (8) |  |  | $ | (7) |
Commodity contracts | 16 |  |  | 4 |  |  | 20 |  |  | 24 |  |  | 36 |  |  | 60 |
Total | $ | 16 |  |  | $ | 1 |  |  | $ | 17 |  |  | $ | 25 |  |  | $ | 28 |  |  | $ | 53 |
| 36 Weeks Ended
| 9/6/2025 |  | 9/7/2024
| Cost of sales |  | Selling, general and administrative expenses |  | Total |  | Cost of sales |  | Selling, general and administrative expenses |  | Total
Foreign exchange contracts | $ | 1 |  |  | $ | 51 |  |  | $ | 52 |  |  | $ | 1 |  |  | $ | 34 |  |  | $ | 35 |
Commodity contracts | 12 |  |  | (6) |  |  | 6 |  |  | 9 |  |  | 16 |  |  | 25 |
Total | $ | 13 |  |  | $ | 45 |  |  | $ | 58 |  |  | $ | 10 |  |  | $ | 50 |  |  | $ | 60 |

X
- Definition Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-9 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2 Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (aa) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2 Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (aaa) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2 Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2 Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3 Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3 Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3 Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3 + Details
Name: | us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4CC -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CC Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4C -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4A -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4A -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the notional amounts of outstanding derivative positions. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1A -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A + Details
Name: | us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4CC -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4A -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4B -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B + Details
Name: | us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration